These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 19149902)

  • 21. BRD7 promoter hypermethylation as an indicator of well differentiated oral squamous cell carcinomas.
    Balasubramanian A; Subramaniam R; Narayanan V; Annamalai T; Ramanathan A
    Asian Pac J Cancer Prev; 2015; 16(4):1615-9. PubMed ID: 25743841
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypermethylation of promoter region of LATS1--a CDK interacting protein in oral squamous cell carcinomas--a pilot study in India.
    Reddy VR; Annamalai T; Narayanan V; Ramanathan A
    Asian Pac J Cancer Prev; 2015; 16(4):1599-603. PubMed ID: 25743838
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular profile of nasopharyngeal carcinoma: analysing tumour suppressor gene promoter hypermethylation by multiplex ligation-dependent probe amplification.
    Ooft ML; van Ipenburg J; van Loo R; de Jong R; Moelans C; Braunius W; de Bree R; van Diest P; Koljenović S; Baatenburg de Jong R; Hardillo J; Willems SM
    J Clin Pathol; 2018 Apr; 71(4):351-359. PubMed ID: 28893862
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Promoter Hypermethylation of the Eyes Absent 4 Gene is a Tumor-Specific Epigenetic Biomarker in Iranian Colorectal Cancer Patients.
    Barati Bagerabad M; Tavakolian S; Abbaszadegan MR; Kerachian MA
    Acta Med Iran; 2018 Jan; 56(1):21-27. PubMed ID: 29436791
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methylated DAPK and APC promoter DNA detection in peripheral blood is significantly associated with apparent residual tumor and outcome.
    Hoffmann AC; Vallböhmer D; Prenzel K; Metzger R; Heitmann M; Neiss S; Ling F; Hölscher AH; Schneider PM; Brabender J
    J Cancer Res Clin Oncol; 2009 Sep; 135(9):1231-7. PubMed ID: 19259700
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HOP/OB1/NECC1 promoter DNA is frequently hypermethylated and involved in tumorigenic ability in esophageal squamous cell carcinoma.
    Yamashita K; Kim MS; Park HL; Tokumaru Y; Osada M; Inoue H; Mori M; Sidransky D
    Mol Cancer Res; 2008 Jan; 6(1):31-41. PubMed ID: 18234960
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic role of APC and RASSF1A promoter methylation status in cell free circulating DNA of operable gastric cancer patients.
    Balgkouranidou I; Matthaios D; Karayiannakis A; Bolanaki H; Michailidis P; Xenidis N; Amarantidis K; Chelis L; Trypsianis G; Chatzaki E; Lianidou ES; Kakolyris S
    Mutat Res; 2015 Aug; 778():46-51. PubMed ID: 26073472
    [TBL] [Abstract][Full Text] [Related]  

  • 28. APC Promoter Hypermethylation as a Prognostic Marker in Breast Cancer Patients.
    Saelee P; Pongtheerat T
    Asian Pac J Cancer Prev; 2020 Dec; 21(12):3627-3632. PubMed ID: 33369461
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic significance of tumor-related genes hypermethylation detected in cancer-free surgical margins of oral squamous cell carcinomas.
    Supic G; Kozomara R; Jovic N; Zeljic K; Magic Z
    Oral Oncol; 2011 Aug; 47(8):702-8. PubMed ID: 21697000
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypermethylation of p16 gene promoter correlates with loss of p16 expression that results in poorer prognosis in esophageal squamous cell carcinomas.
    Fujiwara S; Noguchi T; Takeno S; Kimura Y; Fumoto S; Kawahara K
    Dis Esophagus; 2008; 21(2):125-31. PubMed ID: 18269647
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Relationship between the Methylation of Promoter Regions of Tumor Suppressor Genes PTEN and APC with Endometrial Cancer.
    Ghazanfari T; Asaadi Tehrani G; Maziri P
    Asian Pac J Cancer Prev; 2019 Aug; 20(8):2259-2265. PubMed ID: 31450893
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular detection of p16 promoter methylation in the serum of patients with esophageal squamous cell carcinoma.
    Hibi K; Taguchi M; Nakayama H; Takase T; Kasai Y; Ito K; Akiyama S; Nakao A
    Clin Cancer Res; 2001 Oct; 7(10):3135-8. PubMed ID: 11595706
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Allele loss and promoter hypermethylation of VHL, RAR-beta, RASSF1A, and FHIT tumor suppressor genes on chromosome 3p in esophageal squamous cell carcinoma.
    Kuroki T; Trapasso F; Yendamuri S; Matsuyama A; Alder H; Mori M; Croce CM
    Cancer Res; 2003 Jul; 63(13):3724-8. PubMed ID: 12839965
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inactivation of DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation and its relation to p53 mutations in esophageal squamous cell carcinoma.
    Zhang L; Lu W; Miao X; Xing D; Tan W; Lin D
    Carcinogenesis; 2003 Jun; 24(6):1039-44. PubMed ID: 12807758
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Promoter methylation of MGMT gene in serum of patients with esophageal squamous cell carcinoma in North East India.
    Das M; Sharma SK; Sekhon GS; Saikia BJ; Mahanta J; Phukan RK
    Asian Pac J Cancer Prev; 2014; 15(22):9955-60. PubMed ID: 25520135
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gene promoter hypermethylation in tumors and lymph nodes of stage I lung cancer patients.
    Harden SV; Tokumaru Y; Westra WH; Goodman S; Ahrendt SA; Yang SC; Sidransky D
    Clin Cancer Res; 2003 Apr; 9(4):1370-5. PubMed ID: 12684406
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methylation of APC, TIMP3, and TERT: a new predictive marker to distinguish Barrett's oesophagus patients at risk for malignant transformation.
    Clément G; Braunschweig R; Pasquier N; Bosman FT; Benhattar J
    J Pathol; 2006 Jan; 208(1):100-7. PubMed ID: 16278815
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fields of aberrant CpG island hypermethylation in Barrett's esophagus and associated adenocarcinoma.
    Eads CA; Lord RV; Kurumboor SK; Wickramasinghe K; Skinner ML; Long TI; Peters JH; DeMeester TR; Danenberg KD; Danenberg PV; Laird PW; Skinner KA
    Cancer Res; 2000 Sep; 60(18):5021-6. PubMed ID: 11016622
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of multiple gene hypermethylation in the development of esophageal squamous cell carcinoma.
    Nie Y; Liao J; Zhao X; Song Y; Yang GY; Wang LD; Yang CS
    Carcinogenesis; 2002 Oct; 23(10):1713-20. PubMed ID: 12376481
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LMP gene promoter hypermethylation is a mechanism for its down regulation in Kazak's esophageal squamous cell carcinomas.
    Zheng F; Hasim A; Anwer J; Niyaz M; Sheyhidin I
    Mol Biol Rep; 2013 Mar; 40(3):2069-75. PubMed ID: 23283737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.